Merck cholesterol pill enlicitide and cancer therapy sac-TMT tapped for new priority program FDA expects Merck to submit applications in April and autumn of 2026, documents show Both drugs if approved ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
You can stop looking for glitches in the Matrix—it’s finally been proven that our universe is not merely a simulation running on some powerful alien civilization’s supercomputer. An international team ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Commissioner Marty ...
The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and Sanofi to complete the approval process in one to two months. FDA ...
Oct 16 (Reuters) - The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process, which could potentially get approval within one to two ...
Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...
The FDA has begun accepting applications for a priority pathway designed to slash review times to between one and two months, giving developers of medicines that align with U.S. national health ...
Abstract: Long Range Wide Area Network (LoRaWAN) is a prominent Low-Power Wide-Area Network (LPWAN) technology, widely adopted in IoT applications for its energy efficiency and long-range ...
In a market full of complicated tech, sky-high torque specs, and smartphone apps to control an e-bike, New York-based Priority Bicycles is going in the opposite direction with the launch of its newest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results